Arnaud Bourdin

Dec 5, 2024 | publications.ersnet.org | Michael E. Wechsler |Guy G. Brusselle |J. Christian Virchow |Arnaud Bourdin

IntroductionGlobally, ∼262 million people are affected by asthma [1], resulting in a significant healthcare and economic burden [2]. Asthma is a heterogeneous, chronic lung disease that affects both adults and children [2]. Different underlying disease processes give rise to multiple clinical asthma phenotypes, thereby contributing to the complexity of treatment strategies, particularly because many patients with asthma have overlapping phenotypes (e.g. both eosinophilic and allergic) [3].

Jul 11, 2023 | onlinelibrary.wiley.com | Ian D Pavord |Arnaud Bourdin |Alberto Papi |Christian Domingo

ACQ-5 5-item asthma control questionnaire AQLQ Asthma Quality of Life Questionnaire BD bronchodilator BL baseline CI confidence interval DPL dupilumab FeNO exhaled nitric oxide FEV1 forced expiratory volume in 1 second ICS inhaled corticosteroids IgE immunoglobulin E ITT intention-to-treat NCT national clinical trial PBO placebo ppb parts per billion PSBL parent study baseline Q quartile) q2w every 2 weeks SC subcutaneous) 1 INTRODUCTION Asthma severity is largely identified by the therapy...